Deventer Ziekenhuis
- Address
- lock Available on a paid plan
Cardiovascular Diseases
At Deventer Ziekenhuis, clinical research in cardiovascular diseases focuses on major heart and blood vessel conditions such as acute coronary syndrome, acute myocardial infarction, atrial fibrillation, atherosclerosis, and heart failure. These studies are designed to test new ways to prevent serious events, improve symptom control, and reduce the risk of future complications.
- Preventing major cardiovascular events in high-risk patients
- Improving treatment options for atrial fibrillation and recurrent heart attack risk
- Evaluating therapies for heart failure with inflammation or pulmonary hypertension
- Studying lipid-related risks such as elevated lipoprotein(a) and atherosclerotic disease
Overall, this area reflects a strong interest in better prevention, safer treatment strategies, and more effective long-term cardiovascular care.
Neoplasms
Research in neoplasms at this hospital covers several cancers, including breast cancer, prostate cancer, colon cancer, gastric cancer, esophageal squamous cell carcinoma, and diffuse large B-cell lymphoma. The trials aim to improve cancer control, support survival after surgery or standard treatment, and explore whether newer therapies can add benefit over current care.
- Testing new approaches for early and advanced breast cancer
- Evaluating treatment strategies in prostate cancer and reducing treatment burden
- Studying perioperative and adjuvant options for gastric and colon cancers
- Exploring novel combinations for esophageal cancer and lymphoma
The oncology program at Medical Oncology includes studies that look for better disease control while aiming to preserve quality of life.
Digestive System Diseases
Clinical trials in digestive system diseases address cancers of the colon, stomach, and esophagus. The research is focused on improving outcomes after surgery or chemoradiation and identifying treatment strategies that may lower recurrence risk or extend survival.
- Assessing survival benefits in resected colon carcinoma
- Comparing preoperative treatment approaches for gastric adenocarcinoma
- Studying combined therapy options for esophageal cancer
These trials aim to refine standard cancer care in digestive tract malignancies and support more effective treatment planning.
Female Urogenital Diseases and Pregnancy Complications
Within female urogenital diseases and pregnancy-related research, the site is involved in studies of unexplained subfertility and infertility care. The main goal is to improve the chance of achieving a live birth and to better understand supportive treatment options used during fertility procedures.
- Evaluating ways to improve live birth rates in assisted reproduction
- Studying supportive care in intra-uterine insemination programs
This area reflects a patient-centered effort to make fertility treatment more effective and informative for couples seeking care.
Male Urogenital Diseases
Research in male urogenital diseases centers on prostate cancer, including both newly diagnosed and metastatic disease. The trials are looking at whether treatment can be made more efficient, less toxic, and better tailored to disease risk while maintaining cancer control.
- Studying treatment duration and restart strategies in low-volume metastatic prostate cancer
- Examining how prostate cancer therapy may affect other medications
These studies support more personalized prostate cancer management and may help reduce unnecessary treatment burden.
Skin and Connective Tissue Diseases
The site also conducts research in skin and connective tissue diseases, especially chronic spontaneous urticaria. The trials are focused on improving control of itching and hives in people who do not respond well to standard allergy treatment.
- Testing new options for symptom relief in chronic spontaneous urticaria
- Comparing active treatment with placebo to measure improvement in disease activity
These studies aim to offer better symptom management and a clearer path for patients with persistent allergic skin disease.
Nutritional and Metabolic Diseases
In nutritional and metabolic diseases, research at Deventer Ziekenhuis includes hypertriglyceridemia and broader metabolic risk linked to cardiovascular disease. The purpose of these trials is to see whether newer treatments can improve lipid levels and lower long-term cardiovascular risk.
- Lowering triglyceride levels in patients with severe lipid disorders
- Reducing cardiovascular risk in people with metabolic and atherosclerotic disease
This work connects metabolic care with prevention of heart and vascular complications.
Phenomena and Processes
Trials in metabolism and reproductive and urinary physiological phenomena support research across several disease areas, including heart disease, cancer, and fertility care. These studies are designed to better understand how treatments work in the body and how they may influence clinical outcomes.
- Examining treatment effects on drug handling and metabolism
- Supporting fertility-related research in assisted reproduction
- Investigating biological pathways linked to inflammation and cardiovascular risk
The broader research portfolio shows an interest in both practical treatment improvement and the biological processes behind disease.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 of 19 therapeutic areas and 15 of 169 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 167 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 20 by active trials.
lock +19 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
lock +16 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 271 other sites in The Netherlands
Therapeutic Area Benchmark — The Netherlands
Select a therapeutic area to compare against other sites in The Netherlands.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: The Netherlands
Market Share
Country: The Netherlands
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Deventer Ziekenhuis
lock Showing 1 of 69 trials — the rest is available on a paid plan.
IMP list
lock Showing 1 of 169 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Capecitabine | 7 | Unknown | 2017-06-16 | 2026-07-08 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.